SEC 13F Intelligence

Meyer Handelman Co / LLY

Meyer Handelman Co’s Eli Lilly & Co Position

Does Meyer Handelman Co own Eli Lilly & Co (LLY)? Yes — 27.1K shares worth $25M (+0.78% of its 13F portfolio) as of Q1 2026, down from 27.8K shares the prior filed quarter.

Position Value
$25M
Q1 2026
Shares
27.1K
% of Portfolio
+0.78%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $5MQ2 ’19: $4MQ3 ’19: $4MQ4 ’19: $5MQ4 ’19Q1 ’20: $5MQ2 ’20: $6MQ3 ’20: $6MQ4 ’20: $6MQ4 ’20Q1 ’21: $7MQ2 ’21: $8MQ3 ’21: $8MQ4 ’21: $10MQ4 ’21Q1 ’22: $10MQ2 ’22: $11MQ3 ’22: $11MQ4 ’22: $12MQ4 ’22Q1 ’23: $11MQ2 ’23: $15MQ3 ’23: $17MQ4 ’23: $18MQ4 ’23Q1 ’24: $23MQ2 ’24: $27MQ3 ’24: $26MQ4 ’24: $22MQ4 ’24Q1 ’25: $24MQ2 ’25: $22MQ3 ’25: $21MQ4 ’25: $30MQ4 ’25Q1 ’26: $25Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202627.1K$25M+0.78%
Q4 202527.8K$30M+0.94%
Q3 202527.9K$21M+0.67%
Q2 202528.3K$22M+0.73%
Q1 202528.9K$24M+0.83%
Q4 202429.0K$22M+0.78%
Q3 202429.0K$26M+0.87%
Q2 202429.8K$27M+0.95%
Q1 202430.1K$23M+0.82%
Q4 202331.1K$18M+0.70%
Q3 202331.1K$17M+0.67%
Q2 202331.2K$15M+0.59%
Q1 202331.5K$11M+0.45%
Q4 202232.5K$12M+0.50%
Q3 202233.8K$11M+0.51%
Q2 202234.2K$11M+0.48%
Q1 202234.5K$10M+0.38%
Q4 202136.4K$10M+0.37%
Q3 202136.6K$8M+0.35%
Q2 202136.6K$8M+0.33%
Q1 202136.6K$7M+0.28%
Q4 202036.8K$6M+0.28%
Q3 202037.5K$6M+0.28%
Q2 202037.9K$6M+0.33%
Q1 202038.1K$5M+0.32%
Q4 201938.1K$5M+0.24%
Q3 201938.1K$4M+0.22%
Q2 201938.1K$4M+0.22%
Q1 201938.1K$5M+0.24%
Q4 201838.1K$4M+0.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meyer Handelman Co’s full portfolio or all institutional holders of LLY.